Olaparib in BRCA+ Pancreatic Cancer: Cost-effectiveness Analyzed ...Middle East

Maintenance therapy with olaparib is potentially a cost-effective option in this setting, but this could be improved by tailoring treatment based on individual patient factors. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Olaparib in BRCA+ Pancreatic Cancer: Cost-effectiveness Analyzed )

Also on site :

• Possible tornado in Phelps on Monday
• Evacuations ordered after brush fire breaks out in Laguna Beach
• Photos: A blaze at Cairo telecommunications building causes service disruptions